(Q33890340)

29 July 2017

1 reference

title

Genomic screening for blood-borne viruses in transfusion settings. (English)

1 reference

29 July 2017

Allain JP

1

1 reference

29 July 2017

publication date

1 February 2000

1 reference

International Journal of Laboratory Hematology

29 July 2017

published in

1 reference

29 July 2017

volume

22

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

1-10

1 reference

Routine screening of blood donations for HCV RNA.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

[Residual risks of viral transmission by transfusions and projected yields of additional screening tests. Retrovirus Epidemiology Donors Study (REDS)].

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Nucleic acid technology (NAT) testing and the transfusion service: a rationale for the implementation of minipool testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Screening blood donations for viral genomes: multicenter study of real-time simulation using pooled samples on the model of hepatitis C virus RNA detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Human immunodeficiency virus infection and AIDS in a person with negative serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

HCV and organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Large-scale HCV RNA screening in first-time blood donors: the first step towards genomic screening of blood donations. HCV RNA Screening Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

High throughput PCR detection of HCV based on semiautomated multisample RNA capture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

International standardization of gene amplification technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Identification of a new human immunodeficiency virus type 1 distinct from group M and group O.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Incidence of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England, 1993-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Sensitivity of serological assays to identify blood donors with hepatitis C viraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

A SHOT in the arm for safer blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

The use of polymerase chain reaction in plasma pools for the concomitant detection of hepatitis C virus and HIV type 1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

Detection and characterization of hepatitis C virus RNA in immune globulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2000.00265.X

10.1046/J.1365-2257.2000.00265.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference